These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 8618058)
1. Compound heterozygosity for nonsense ans missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa. McGarth JA; Christiano AM; Pulkkinen L; Eady RA; Uitto J J Invest Dermatol; 1996 May; 106(5):1157-9. PubMed ID: 8618058 [TBL] [Abstract][Full Text] [Related]
2. Compound heterozygosity for nonsense and missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa. Christiano AM; Pulkkinen L; Eady RA; Uitto J J Invest Dermatol; 1996 Apr; 106(4):775-7. PubMed ID: 8618020 [TBL] [Abstract][Full Text] [Related]
3. Laminin 5 genes and Herlitz junctional epidermolysis bullosa: novel mutations and polymorphisms in the LAMB3 and LAMC2 genes. Mutations in brief no. 190. Online. Kon A; Pulkkinen L; Hara M; Tamai K; Tagami H; Hashimoto I; Uitto J Hum Mutat; 1998; 12(4):288. PubMed ID: 10660342 [TBL] [Abstract][Full Text] [Related]
4. Novel compound heterozygous mutation in LAMC2 genes (c.79G>A and 382insT) in Herlitz junctional epidermolysis bullosa. Jeon IK; Kim SE; Kim SC J Dermatol; 2014 Apr; 41(4):322-4. PubMed ID: 24533970 [TBL] [Abstract][Full Text] [Related]
5. Novel mutations in the LAMB3 gene shared by two Japanese unrelated families with Herlitz junctional epidermolysis bullosa, and their application for prenatal testing. Takizawa Y; Shimizu H; Pulkkinen L; Hiraoka Y; McGrath JA; Suzumori K; Aiso S; Uitto J; Nishikawa T J Invest Dermatol; 1998 Feb; 110(2):174-8. PubMed ID: 9457915 [TBL] [Abstract][Full Text] [Related]
6. A homozygous nonsense mutation in the alpha 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa. Kivirikko S; McGrath JA; Baudoin C; Aberdam D; Ciatti S; Dunnill MG; McMillan JR; Eady RA; Ortonne JP; Meneguzzi G Hum Mol Genet; 1995 May; 4(5):959-62. PubMed ID: 7633458 [TBL] [Abstract][Full Text] [Related]
7. Moderation of phenotypic severity in dystrophic and junctional forms of epidermolysis bullosa through in-frame skipping of exons containing non-sense or frameshift mutations. McGrath JA; Ashton GH; Mellerio JE; Salas-Alanis JC; Swensson O; McMillan JR; Eady RA J Invest Dermatol; 1999 Sep; 113(3):314-21. PubMed ID: 10469327 [TBL] [Abstract][Full Text] [Related]
8. Herlitz junctional epidermolysis bullosa: novel and recurrent mutations in the LAMB3 gene and the population carrier frequency. Nakano A; Pfendner E; Hashimoto I; Uitto J J Invest Dermatol; 2000 Sep; 115(3):493-8. PubMed ID: 11023379 [TBL] [Abstract][Full Text] [Related]
9. Molecular analysis of the human laminin alpha3a chain gene (LAMA3a): a strategy for mutation identification and DNA-based prenatal diagnosis in Herlitz junctional epidermolysis bullosa. Pulkkinen L; Cserhalmi-Friedman PB; Tang M; Ryan MC; Uitto J; Christiano AM Lab Invest; 1998 Sep; 78(9):1067-76. PubMed ID: 9759651 [TBL] [Abstract][Full Text] [Related]
11. A homozygous nonsense mutation in the beta 3 chain gene of laminin 5 (LAMB3) in Herlitz junctional epidermolysis bullosa. Pulkkinen L; Christiano AM; Gerecke D; Wagman DW; Burgeson RE; Pittelkow MR; Uitto J Genomics; 1994 Nov; 24(2):357-60. PubMed ID: 7698759 [TBL] [Abstract][Full Text] [Related]
12. Predominance of the recurrent mutation R635X in the LAMB3 gene in European patients with Herlitz junctional epidermolysis bullosa has implications for mutation detection strategy. Pulkkinen L; Meneguzzi G; McGrath JA; Xu Y; Blanchet-Bardon C; Ortonne JP; Christiano AM; Uitto J J Invest Dermatol; 1997 Aug; 109(2):232-7. PubMed ID: 9242513 [TBL] [Abstract][Full Text] [Related]
13. Laminin-5 mutational analysis in an Italian cohort of patients with junctional epidermolysis bullosa. Posteraro P; De Luca N; Meneguzzi G; El Hachem M; Angelo C; Gobello T; Tadini G; Zambruno G; Castiglia D J Invest Dermatol; 2004 Oct; 123(4):639-48. PubMed ID: 15373767 [TBL] [Abstract][Full Text] [Related]
14. Identification of a homozygous one-basepair deletion in exon 14 of the LAMB3 gene in a patient with Herlitz junctional epidermolysis bullosa and prenatal diagnosis in a family at risk for recurrence. Vailly J; Pulkkinen L; Miquel C; Christiano AM; Gerecke D; Burgeson RE; Uitto J; Ortonne JP; Meneguzzi G J Invest Dermatol; 1995 Apr; 104(4):462-6. PubMed ID: 7706759 [TBL] [Abstract][Full Text] [Related]
16. Altered laminin 5 expression due to mutations in the gene encoding the beta 3 chain (LAMB3) in generalized atrophic benign epidermolysis bullosa. McGrath JA; Pulkkinen L; Christiano AM; Leigh IM; Eady RA; Uitto J J Invest Dermatol; 1995 Apr; 104(4):467-74. PubMed ID: 7706760 [TBL] [Abstract][Full Text] [Related]
17. Molecular basis of non-lethal junctional epidermolysis bullosa: identification of a 38 basepair insertion and a splice site mutation in exon 14 of the LAMB3 gene. Cserhalmi-Friedman PB; Baden H; Burgeson RE; Christiano AM Exp Dermatol; 1998; 7(2-3):105-11. PubMed ID: 9583749 [TBL] [Abstract][Full Text] [Related]
18. A recurrent laminin 5 mutation in British patients with lethal (Herlitz) junctional epidermolysis bullosa: evidence for a mutational hotspot rather than propagation of an ancestral allele. Ashton GH; Mellerio JE; Dunnill MG; Pulkkinen L; Christiano AM; Uitto J; Eady RA; McGrath JA Br J Dermatol; 1997 May; 136(5):674-7. PubMed ID: 9205497 [TBL] [Abstract][Full Text] [Related]
19. Maternal uniparental meroisodisomy in the LAMB3 region of chromosome 1 results in lethal junctional epidermolysis bullosa. Takizawa Y; Pulkkinen L; Shimizu H; Lin L; Hagiwara S; Nishikawa T; Uitto J J Invest Dermatol; 1998 May; 110(5):828-31. PubMed ID: 9579554 [TBL] [Abstract][Full Text] [Related]
20. Mutational hotspots in the LAMB3 gene in the lethal (Herlitz) type of junctional epidermolysis bullosa. Kivirikko S; McGrath JA; Pulkkinen L; Uitto J; Christiano AM Hum Mol Genet; 1996 Feb; 5(2):231-7. PubMed ID: 8824879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]